BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 20101403)

  • 1. Contrast-enhanced ultrasonography of hepatocellular carcinoma after chemoembolisation using drug-eluting beads: a pilot study focused on sustained tumor necrosis.
    Moschouris H; Malagari K; Papadaki MG; Kornezos I; Matsaidonis D
    Cardiovasc Intervent Radiol; 2010 Oct; 33(5):1022-7. PubMed ID: 20101403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the microcirculation of hepatocellular carcinomas using contrast-enhanced ultrasound with intraarterial and intravenous contrast application during transarterial chemoembolization with drug-eluting beads (DEB-TACE): preliminary data.
    Uller W; Wiggermann P; Gössmann H; Klebl F; Salzberger B; Stroszczynski C; Jung EM
    Clin Hemorheol Microcirc; 2011; 49(1-4):55-66. PubMed ID: 22214678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unenhanced and contrast-enhanced ultrasonography during hepatic transarterial embolization and chemoembolization with drug-eluting beads.
    Moschouris H; Malagari K; Kornezos I; Papadaki MG; Gkoutzios P; Matsaidonis D
    Cardiovasc Intervent Radiol; 2010 Dec; 33(6):1215-22. PubMed ID: 20556386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive factors of contrast-enhanced ultrasonography for the response to transarterial chemoembolization in hepatocellular carcinoma.
    Park KH; Kwon SH; Lee YS; Jeong SW; Jang JY; Lee SH; Kim SG; Cha SW; Kim YS; Cho YD; Kim HS; Kim BS; Kim YJ
    Clin Mol Hepatol; 2015 Jun; 21(2):158-64. PubMed ID: 26157753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transarterial chemoembolization of unresectable hepatocellular carcinoma with drug eluting beads: results of an open-label study of 62 patients.
    Malagari K; Chatzimichael K; Alexopoulou E; Kelekis A; Hall B; Dourakis S; Delis S; Gouliamos A; Kelekis D
    Cardiovasc Intervent Radiol; 2008; 31(2):269-80. PubMed ID: 17999110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Image fusion with volume navigation of contrast enhanced ultrasound (CEUS) with computed tomography (CT) or magnetic resonance imaging (MRI) for post-interventional follow-up after transcatheter arterial chemoembolization (TACE) of hepatocellular carcinomas (HCC): Preliminary results.
    Ross CJ; Rennert J; Schacherer D; Girlich C; Hoffstetter P; Heiss P; Jung W; Feuerbach S; Zorger N; Jung EM
    Clin Hemorheol Microcirc; 2010; 46(2-3):101-15. PubMed ID: 21135486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transarterial chemoembolization for hepatocellular carcinoma with a new generation of beads: clinical-radiological outcomes and safety profile.
    Spreafico C; Cascella T; Facciorusso A; Sposito C; Rodolfo L; Morosi C; Civelli EM; Vaiani M; Bhoori S; Pellegrinelli A; Marchianò A; Mazzaferro V
    Cardiovasc Intervent Radiol; 2015 Feb; 38(1):129-34. PubMed ID: 24870698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transarterial Chemoembolization of HCC with Radiopaque Microspheres: Evaluation with Computed Tomography and the Complementary Role of Contrast-Enhanced Ultrasonography.
    Moschouris H; Malagari K; Dimakis A; Kiakidis T; Anagnostopoulou A
    Cardiovasc Intervent Radiol; 2020 Jul; 43(7):1075-1083. PubMed ID: 32394087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival, efficacy, and safety of small versus large doxorubicin drug-eluting beads TACE chemoembolization in patients with unresectable HCC.
    Prajapati HJ; Xing M; Spivey JR; Hanish SI; El-Rayes BF; Kauh JS; Chen Z; Kim HS
    AJR Am J Roentgenol; 2014 Dec; 203(6):W706-14. PubMed ID: 25415737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immediate post-doxorubicin drug-eluting beads chemoembolization Mr Apparent diffusion coefficient quantification predicts response in unresectable hepatocellular carcinoma: A pilot study.
    Kokabi N; Camacho JC; Xing M; Edalat F; Mittal PK; Kim HS
    J Magn Reson Imaging; 2015 Oct; 42(4):981-9. PubMed ID: 25683022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-Eluting Beads Loaded With Doxorubicin (DEBDOX) Chemoembolisation Before Liver Transplantation for Hepatocellular Carcinoma: An Imaging/Histologic Correlation Study.
    Pauwels X; Azahaf M; Lassailly G; Sergent G; Buob D; Truant S; Boleslawski E; Louvet A; Gnemmi V; Canva V; Mathurin P; Pruvot FR; Leteurtre E; Ernst O; Dharancy S
    Cardiovasc Intervent Radiol; 2015 Jun; 38(3):685-92. PubMed ID: 25342136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement patterns of hepatocellular carcinoma after transarterial chemoembolization using drug-eluting beads on arterial phase CT images: a pilot retrospective study.
    Chung WS; Lee KH; Park MS; Lee YJ; Kwon J; Baek SE; Kim MJ
    AJR Am J Roentgenol; 2012 Aug; 199(2):349-59. PubMed ID: 22826396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preservation of quality of life with doxorubicin drug-eluting bead transarterial chemoembolization for unresectable hepatocellular carcinoma: Longitudinal prospective study.
    Xing M; Webber G; Prajapati HJ; Chen Z; El-Rayes B; Spivey JR; Pillai AA; Kim HS
    J Gastroenterol Hepatol; 2015 Jul; 30(7):1167-74. PubMed ID: 25675849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Triple-Drug Transcatheter Arterial Chemoembolization (TACE) With Single-Drug TACE Using Doxorubicin-Eluting Beads: Long-Term Survival in 313 Patients.
    Gomes AS; Monteleone PA; Sayre JW; Finn RS; Sadeghi S; Tong MJ; Britten CD; Busuttil RW
    AJR Am J Roentgenol; 2017 Oct; 209(4):722-732. PubMed ID: 28705059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contrast-enhanced ultrasonography with intraarterial administration of SonoVue for guidance of transarterial chemoembolization: an initial experience.
    Moschouris H; Malagari K; Kalokairinou M; Stamatiou K; Marinis A; Papadaki MG
    Med Ultrason; 2011 Dec; 13(4):296-301. PubMed ID: 22132402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective randomized comparison of chemoembolization with doxorubicin-eluting beads and bland embolization with BeadBlock for hepatocellular carcinoma.
    Malagari K; Pomoni M; Kelekis A; Pomoni A; Dourakis S; Spyridopoulos T; Moschouris H; Emmanouil E; Rizos S; Kelekis D
    Cardiovasc Intervent Radiol; 2010 Jun; 33(3):541-51. PubMed ID: 19937027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of DC beads in hepatocellular carcinoma: clinical and radiological results of a drug delivery device for transcatheter superselective arterial embolization.
    Sadick M; Haas S; Loehr M; Elshwi M; Singer MV; Brade J; Schoenberg SO; Diehl SJ
    Onkologie; 2010; 33(1-2):31-7. PubMed ID: 20164659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatocellular carcinoma: CT for tumor response after transarterial chemoembolization in patients exceeding Milan criteria--selection parameter for liver transplantation.
    Bargellini I; Vignali C; Cioni R; Petruzzi P; Cicorelli A; Campani D; De Simone P; Filipponi F; Bartolozzi C
    Radiology; 2010 Apr; 255(1):289-300. PubMed ID: 20308465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase I/II trial of chemoembolization for hepatocellular carcinoma using a novel intra-arterial drug-eluting bead.
    Poon RT; Tso WK; Pang RW; Ng KK; Woo R; Tai KS; Fan ST
    Clin Gastroenterol Hepatol; 2007 Sep; 5(9):1100-8. PubMed ID: 17627902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and effectiveness of chemoembolization with drug-eluting beads for advanced-stage hepatocellular carcinoma.
    Kalva SP; Pectasides M; Liu R; Rachamreddy N; Surakanti S; Yeddula K; Ganguli S; Wicky S; Blaszkowsky LS; Zhu AX
    Cardiovasc Intervent Radiol; 2014 Apr; 37(2):381-7. PubMed ID: 23754191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.